Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

University of Ulster Spin-out Unveils Breakthrough Vital Sign Monitors

24.06.2008
Innovative medical technology developed by a University of Ulster spinout company is set to transform the way doctors monitor their patients’ hearts and other vital signs, it was revealed today.

A tiny device invented by spinout company ST+D will enable clinicians to assess a patient’s condition irrespective of where they are. The “no wires” technology will also help to reduce patients’ time in hospital and free up beds more quickly.

“It won’t matter whether the patient is in hospital, at home recuperating - or holidaying in, say, Spain or South Africa,” according to chief executive Michael Caulfield. “Doctors will be able to click onto a website and review the state of their patients’ health.”

The breakthrough is based on a disposable adhesive electrode patch worn on the patient’s chest. A small electronic unit with wireless technology is attached which sends processed signals back to the doctor.

The company has revealed that a specific version of the device is now being developed by ST+D and clinically trialled in collaboration with the Royal Victoria Hospital in a project which has been funded by the Wellcome Trust, the UK’s largest medical research charity. This programme-related investment by the Trust is the first of its kind for a private sector business in Northern Ireland.

The device is the outcome of pioneering research by the principal investigators Professors John Anderson, Jim McLaughlin and Eric McAdams at the University of Ulster’s Nanotechnology and Integrated Bioengineering Centre (NIBEC) who are founders and directors of ST+D. It is hoped that following the product development phase its manufacture will take place in Belfast, leading to new jobs at the award-winning Northern Ireland firm.

Ted Bianco, Director of Technology Transfer at the Wellcome Trust, said: “Our translation awards are designed to facilitate the development of medical products in areas of unmet need in healthcare. In this way, the Wellcome Trust aims to bridge the gap between a good idea and an innovative tool with the potential to improve the lives of patients.”

“This device certainly has the potential to change the way doctors monitor their patients’ hearts. Testing it in a hospital environment is the first step to validating the technology and gaining useful insights into how it might best be deployed, both in the clinical setting and beyond.”

The 18-month roll-out period is attracting international attention, according to Michael Caulfield, whose company specialising in wireless “vital signs” medical technology is based at Heron Road in Belfast.

“It will free up hospital beds because of earlier release of heart patients and cut down on in-patients’ appointments, while at the same time giving early warning of any problems,” he added. “While it’s not designed to provide emergency alerts this technology will certainly warn the clinician of one that may possibly be impending – and of which the patient is unaware. This technology solution will be of significant interest to healthcare organisations on a global basis”

The sensor includes on-board intelligence allowing it to monitor and record irregular heart events and to capture heart data for periods of time before and after those events. Future versions of the device will also measure the wearer’s respiratory rate, temperature and oxygen in the blood.

Within a hospital environment, this device will work from up to 10 metres away, un-tethering the patient from wires. When patients are discharged the clinician will have the option to provide the patient with a small handset suitable for bedside table, pocket or handbag which will pick up the signals from the patch using GPRS, (the global system for mobile communications) and transmit the signals onwards to a doctor's computer via the world-wide web.

David Young | alfa
Further information:
http://www.ulster.ac.uk

More articles from Medical Engineering:

nachricht Novel PET imaging agent could help guide therapy for brain diseases
03.04.2018 | Society of Nuclear Medicine and Molecular Imaging

nachricht New Computer Architecture: Time Lapse for Dementia Research
29.03.2018 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>